Prenner J, Rentfro K, Vleugels RA, Shahriari N GLP-1 Receptor Agonist Therapy in Patients With Extragenital Lichen Sclerosus , JAMA Dermatol, 162(6): 2026,657-659
Alnajjar NF, Camillucci MM, Prenner J, Vleugels RA, Castillo RL Evaluation of GLP-1-receptor agonist use in patients with idiopathic inflammatory myopathies: a retrospective analysis , Global Conference on Myositis, Lisbon, Portugal: 2026
He A, Gerera C, Acevedo L, Stone J, Prenner J, Vleugels RA, Castillo RL Steroid induced myopathy and toxicity among dermatomyositis patients using the glucocorticoid toxicity index , Global Conference on Myositis, Lisbon, Portugal: 2026
Castillo RL, Shaw KS, Rentfro K, Hashemi K, Prenner J, Shayegan L, Kim YJ, Camillucci M, Smith NA, Vleugels RA Anifrolumab use in pregnancy: maternal and neonatal outcomes in patients with systemic lupus erythematosus , EULAR Rheumatol, 2(1): 2026,223-225
Mittal S, Goorman EJ, Prenner J, Guhan S, Zheng L, Choi JN, Nguyen CV Vulvar and anogenital ulcerations induced by amivantamab: A case series , JAAD Case Rep, 70: 2026,49-51
Kim YJ, Prenner J, Rentfro K, Shayegan LH, Camillucci M, Vleugels RA, Shahriari N Venous thromboembolic risk of combination therapy with intravenous immunoglobulin and Janus kinase inhibitors in dermatomyositis: A retrospective cohort study , J Am Acad Dermatol, 94(1): 2026,368-69
He A, Gerera C, Acevedo L, Camillucci MM, Vleugels RA, Prenner J, Castillo RL Steroid induced myopathy and toxicity among dermatomyositis patients using the glucocorticoid toxicity index (GTI) , Rheumatologic Dermatology Society Annual Meeting, Chicago, IL: 2025
Whittelsey M, Prenner J*, Chang J et al Adult reactive of childhood-onset blaschkolinear morphea , Massachusetts Academy of Dermatology Annual Meeting, Newport, RI: 2025
Mittal S, Prenner J, Nguyen CV Hypertrophic red-brown plaques , JAMA Dermatology, 161(9): 2025,974-75
Breedveld S, Prenner J, Zhao G, Shastry JL, Nguyen CV Autoantibodies and malignancy risk in patients with vesiculobullous dermatomyositis , Rheumatology (Oxford), 64(8): 2025,4846-48
